*Seminar Series: CASB Seminar
*Location: IMB Large Seminar Room
*Date: 24/08/2017
*Time: 12:30

Speaker #1 details
*Title of talk: Bioanalytical-focused lead discovery and pre-clinical drug development
*Speaker's name: Dr Mark Butler
*Speaker's organisation: Institute for Molecular Bioscience
Speaker's city/state/country:
Talk Abstract: The discovery and validation of new drug leads is the critical first step in the drug development process. In this talk, approaches to this discovery and validation process will be illustrated for anti-invectives and inflammatory targets using a series of vignettes that highlight mass spectrometry, NMR and bioinformatics approaches.
Speaker's bio: BSc Hons (1988) and PhD (1993) from The University of Melbourne, and MBA (2017 pending) from The University of Queensland. Mark's post degree research career commenced with a postdoctoral appointment at the Cancer Research Institute, Arizona State University (Jan 1993 to Sept 1994), then advanced to natural product lead discovery with AstraZeneca at Queensland Pharmaceutical Research Institute, Griffith University (Oct 1994 to Sept 1999), Head of Natural Product Lead Discovery with GSK at the Centre for Natural Product Research in Singapore (Nov 1999 to April 2002), and the Director Natural Product Chemistry at MerLion Pharmaceuticals (May 2002 to Aug 2009). During his time in Singapore Mark held an Adjunct Associate Professorship in the Chemistry Department at the National University of Singapore. Mark, renowned for his excellent and highly cited reviews in the broad field of natural product drug discovery, joined IMB (Cooper Group) in 2009 to advance new initiatives in anti-infective and anti-inflammatory drug discovery and development.

Speaker #2 details
*Title of talk:
*Speaker's name:
*Speaker's organisation:
Speaker's city/state/country:
Talk Abstract:
Speaker's bio:

Other Details:
*Host name: Prof Rob Capon
Host phone number:
*Host email: r.capon@uq.edu.au